Skip to main content

Table 2 Characteristics of include studies

From: Serum cystatin C is associated with the prognosis in acute myocardial infarction patients after coronary revascularization: a systematic review and meta-analysis

Author/year Patients Intervention Outcome Adjustment
Ichimoto/2009 [28] STEMI PCI Cardiovascular events Age; Killip class;
Time from hospital presentation to angioplasty;
Prior myocardial infarction; Creatinine;
Silva/2012 [7] STEMI PCI Death/reinfarction LVEF;
Sun/2012 [8] AMI PCI Major adverse cardiac events NA;
Akgul/2013 [9] STEMI PCI Major adverse cardiac events Age; gender; diabetes; hypertension; Killip class; anemia; renal failure; No-reflow; Three-vessel disease; unsuccessful procedure; LVEF;
Angeli/2015 [29] non-ST-elevation ACS PCI All-cause mortality Age; gender; diabetes; unsuccessful PCI; LVEF; Multivessel disease; Statin prescription at discharge; eGFR;
Lee/2015 [18] ACS CABG Mortality and major adverse cerebrovascular and cardiovascular events NA;
Dardashti/2016 [30] CHD CABG All-cause mortality Age; LVEF; logarithm of time in ICU; hemoglobin; plasma transfused; creatinine;
Shen/2018 [31] STEMI PCI Major adverse cardiac events Age; SBP ≥ 140 (mmHg); NT-proBNP; eGFR; LVEF;
  1. PCI percutaneous coronary intervention, CABG coronary artery bypass grafting, LVEF left ventricular ejection fraction, SBP systolic blood pressure, eGFR estimate glomerular filtration rate, ICU intensive care unit, m month, y year, NA not applicable, STEMI ST-elevation myocardial infarction, ACS acute coronary syndrome, CHD coronary heart disease